BioStock: Medivir’s partner makes clinical progress in veterinary project

Medivir’s partner Vetbiolix has reported positive results from a clinical proof-of-concept study in periodontal disease in dogs with one of Medivir’s drug candidates. In a comment to BioStock, Medivir’s CEO Jens Lindberg emphasizes that it is proof of the company’s ability to establish successful partnerships.

Read the article at biostock.se:

https://www.biostock.se/en/2024/04/medivirs-partner-makes-clinical-progress-in-veterinary-project/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/